EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of estradiol-17 beta treatment of gilts on blood mononuclear cell functions in vitro






American Journal of Veterinary Research 53(8): 1427-1430

Effect of estradiol-17 beta treatment of gilts on blood mononuclear cell functions in vitro

Porcine blood mononuclear cells (BMC) were exposed to prepartum concentration of estrogen in gilts before acquisition (in vivo), and their subsequent reactivity (in vitro) was explored. In a cross-over experimental designed study, 6 ovariectomized gilts were injected once with 3.75 mg of estradiol-17 beta benzoate in arachidic oil or with arachidic oil only during 2 experiments. The ability of their BMC to proliferate in response to stimulation with phytohemagglutinin, concanavalin A, and pokeweed mitrogen was assayed in cultures of blood and in cultures of purified BMC. After 2 days of mitogen stimulation, activity of accessible interleukin 2 was quantified in supernatants obtained from cultures of purified BMC and supernatants of blood cultures stimulated with pokeweed mitogen. Also, production of immunoglobulins by purified BMC in response to polyclonal stimuli was measured. Three days after treatment with estradiol, the proliferative response was suppressed in blood cultures stimulated with concanavalin A (P less than 0.05) and phytohemagglutinin (P less than 0.07). Effects of estradiol treatment were not found in any of the assays performed with purified BMC. We, therefore, assumed that in vivo exposure to estradiol can affect the function of porcine BMC; however, this was only evident when the in vitro assays were performed on blood cultures.


Accession: 002355437

PMID: 1510321



Related references

Effect of estradiol-17b treatment of gilts on blood mononuclear cell functions in vitro. American Journal of Veterinary Research 53: 27-30, 1992

Effect of glucose concentration, osmolality, and sterilization process of peritoneal dialysis fluids on cytokine production by peripheral blood mononuclear cells and polymorphonuclear cell functions in vitro. American Journal of Kidney Diseases 31(2): 273-282, 1998

The effect of beta -glucan of cell wall from Candida albicans on interleukin-6 and interleukin-8 production by human peripheral blood mononuclear cells in vitro. Journal of Clinical Dermatology 31(6): 349-350, 2002

Changes of cytokine production and cell viability of peripheral blood mononuclear cells from silicosis patients: effect of in vitro treatment with acetylsalicylic acid. Toxicology and Industrial Health 26(1): 3-9, 2010

Effects of exogenous estradiol 17 beta on luteinizing hormone progesterone and estradiol 17 beta concentration before and after prostaglandin f 2 alpha induced termination of pregnancy and pseudopregnancy in gilts. Journal of Animal Science 70(2): 518-524, 1992

Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcoholism, Clinical and Experimental Research 13(5): 636-643, 1989

Effect of 17 beta -estradiol on pituitary gonadotropins and luteal function in gilts. Journal of Animal Science 34(3): 427-429, 1972

In vitro production of TNF-alpha, IL-1 beta and IL-6 by mononuclear blood cells of patients with renal cell carcinoma undergoing rIL-2 treatment. Relation between clinical response and TNF-alpha production. Cytokine 4(2): 144-150, 1992

Effect of progestogens and estradiol 17 beta on the dynamics of estradiol 17 beta metabolism in rabbit uterus in vitro. Journal of Steroid Biochemistry 25(SUPPL): 65S, 1986

Ex vivo effect of pidotimod on peripheral blood mononuclear cell immune functions: Study of an elderly population. International Journal of Immunotherapy 10(1): 35-39, 1994